The 2nd Connors et al. paper of 2024 is now out!!
JCI Insight - possibly the most painful journal to work with to date in my career - but it is out in “print” officially!
Kaleigh wrote a great tweet-orial about it here.
This was and is a fun collaboration. The whole goal of developing the models over the years is to use them for testing countermeasures. This is the second study working with Jim Crowe’s group at Vanderbilt to evaluate neutralizing anti-RVFV mAbs in one of our disease models. The first was in the pregnant rat model.
This latest paper is the first to evaluate mAbs in the context of aerosol exposure and neurological disease - a very high bar for protection. This is just the beginning because we have additional studies planned.